HOME
ABOUT US
OUR COMPANY
OUR TEAM
BOARD OF DIRECTORS
INVESTORS
CAREERS
T-GUARD®
CHARACTERISTICS
DEVELOPMENT PLAN
GRAFT-VERSUS-HOST
ADDITIONAL INDICATIONS
EXPANDED ACCESS
A PATIENT’S STORY
NEWS & EVENTS
NEWS
EVENTS
IN THE MEDIA
PARTNERING
PARTNERING FOR PROGRESS
CONTACT
2013
Filter by
Languages
Skill level
Authors
Show all
All
Press-releases
All
2019
2018
2017
2016
2015
2014
2013
2012
All
Jeroen Schumacher
MauriceHampsink
18 september 2013
18 september 2013
T-Guard® Receives Orphan Drug Designation for Treatment of GVHD in the US
